Below is a list of research done on black raspberries.  They are sorted under very general categories with the link titles giving a description of the research focus.

General Scientific Black Raspberry Publications:

• Foodstuffs for preventing cancer: the preclinical and clinical development of berries.
• Anthocyanins and their role in cancer prevention.
• Laboratory and clinical studies of cancer chemoprevention by antioxidants in berries.
• Bioactive food components and cancer risk reduction.
• Cancer prevention with freeze-dried berries and berry components.
• Molecular mechanisms involved in chemoprevention of black raspberry extracts: from transcription factors to their target genes.
• Pharmacokinetics of anthocyanins and ellagic acid in healthy volunteers fed freeze-dried black raspberries daily for 7 days.
• Black raspberry extract and fractions contain angiogenesis inhibitors.
• Inhibition of cellular transformation by berry extracts.
• Perspectives in cancer chemoprevention.
• Cancer chemoprevention: principles and prospects.

Black raspberry and the lower GI tract:

• Effect of black raspberry ( Rubus occidentalis L.) extract variation conditioned by cultivar, production site, and fruit maturity stage on colon cancer cell proliferation.
• Modulation of genetic and epigenetic biomarkers of colorectal cancer in humans by black raspberries: a phase I pilot study.
• Anti-inflammatory effects of freeze-dried black raspberry powder in ulcerative colitis.
• Black raspberries inhibit intestinal tumorigenesis in apc1638+/- and Muc2-/- mouse models of colorectal cancer.
• Intestinal epithelial cell accumulation of the cancer preventive polyphenol ellagic acid–extensive binding to protein and DNA.

Black raspberry and the upper GI tract:

• Effects of human oral mucosal tissue, saliva, and oral microflora on intraoral metabolism and bioactivation of black raspberry anthocyanins.
• Black raspberry components inhibit proliferation, induce apoptosis, and modulate gene expression in rat esophageal epithelial cells.
• Formulation and in vitro-in vivo evaluation of black raspberry extract-loaded PLGA/PLA injectable millicylindrical implants for sustained delivery of chemopreventive anthocyanins.
• A rapid and sensitive LC-MS/MS method for quantification of four anthocyanins and its application in a clinical pharmacology study of a bioadhesive black raspberry gel.
• Distribution of anthocyanins delivered from a bioadhesive black raspberry gel following topical intraoral application in normal healthy volunteers.
• Topical application of a bioadhesive black raspberry gel modulates gene expression and reduces cyclooxygenase 2 protein in human premalignant oral lesions.
• Effects of a topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesions.
• Prevention and therapy of squamous cell carcinoma of the rodent esophagus using freeze-dried black raspberries.
• Transitioning from preclinical to clinical chemopreventive assessments of lyophilized black raspberries: interim results show berries modulate markers of oxidative stress in Barrett’s esophagus patients.
• Suppression of the tumorigenic phenotype in human oral squamous cell carcinoma cells by an ethanol extract derived from freeze-dried black raspberries.
• Modulation of N-nitrosomethylbenzylamine metabolism by black raspberries in the esophagus and liver of Fischer 344 rats.
• Black raspberries inhibit N-nitrosomethylbenzylamine (NMBA)-induced angiogenesis in rat esophagus parallel to the suppression of COX-2 and iNOS.
• Inhibition of the growth of premalignant and malignant human oral cell lines by extracts and components of black raspberries.
• Chemoprevention of oral cancer by black raspberries.
• Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries.
• Inhibition of N-nitrosobenzylmethylamine metabolism and DNA binding in cultured rat esophagus by ellagic acid.